| abstract |
The present invention relates to a matrix type transdermal patch, characterized in that it contains a nonvolatile menthol derivative as an essential component as a transdermal absorption accelerator.n n n The matrix transdermal patch of the present invention comprises a drug protection layer, an effective drug-containing matrix layer, and a peeling layer removed before adhesion to the skin, wherein the matrix layer is 1 to 25% by weight of the effective drug, 40 to 95% by weight of a pressure-sensitive adhesive, and It contains 1 to 30% by weight of nonvolatile menthol derivatives as a transdermal absorption accelerator.n n n In addition, the matrix layer may further comprise up to 30% by weight of a dissolution aid. |